Login
$SERA
$1.94 -$0.07 (3.48%) Live

Company Executives

Officer Age In this role 2025 pay Source
Zhenya Lindgardt Also a director
President and Chief Executive Officer
52 Not stated $2,033,811
Scott Gleason
Chief Financial Officer and Treasurer
Title from the Form 8-K dated Aug 31, 2026
Not stated Not stated Not reported
Lee Anderson
Chief Commercial Officer
62 Since 2025
1 year
Not reported
Tiffany Inglis
Chief Medical Officer
50 Since 2025
1 year
Not reported
Benjamin G. Jackson
General Counsel
47 Since 2021
5 years
Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 24, 2026 · updated by the 8-Ks of Jun 1, 2026 and Jun 30, 2026

Directors
8
serving now
Independent
1 of 1
stated in the proxy; 7 not stated
Average tenure
10.3 years
from year joined
CEO also chairs the board
No
Kim Kamdar
Director Age On board Independent Committees Other public boards 2025 pay Source
Kim Kamdar
58 2011
15 years
Not stated
Compensation Committee · Chair Nominating and Governance Committee
Seraphina Therapeutics, Truvian Sciences, Inc., Evofem Biosciences, Inc., Singular Genomics Systems Not stated
Zhenya Lindgardt
52 2021
5 years
Not stated None stated None stated Paid as CEO
Sandra A. J. Lawrence
68 2021
5 years
Not stated
Audit Committee · Chair
Evergy, Inc. $99,908
Gregory C. Critchfield
74 2010
16 years
Not stated None stated None stated $84,908
Joshua Phillips
59 2011
15 years
Not stated
Audit Committee Compensation Committee
None stated $97,408
Jane F. Barlow
65 2022
4 years
Not stated
Nominating and Governance Committee · Chair
None stated $93,408
Mansoor Raza Mirza
65 2014
12 years
Not stated
Nominating and Governance Committee
None stated $88,908
Mark Capone Joined Jul 1, 2026
- - Independent
Compensation Committee
- -

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

8 disclosed in the proxy filed Apr 24, 2026
Elevance Health
Listed under the heading Agreements with Stockholders
Amount not stated

Commercial Collaboration Agreement for use of the PreTRM test within Elevance Health's network, with minimum purchase and payment commitments for the first three years.

Elevance Health
Listed under the heading Agreements with Stockholders
Amount not stated

Laboratory Services Agreement for provision of PreTRM tests and related services during the PRIME study.

Baker Bros.
Principal stockholder
Amount not stated

Amended side letter giving Baker Bros. the right to nominate one Investor Designee to the board while it owns at least 19.9% of total voting power.

Certain holders of our capital stock
Holders of registrable shares under the Investors' Rights Agreement
Amount not stated

Fourth Amended and Restated Investors' Rights Agreement granting registration rights for resale of their shares.

Baker Bros.
Principal stockholder
Amount not stated
February 2025

Entities affiliated with Baker Bros. purchased Pre-Funded Warrants in the public offering to purchase 11,250,000 shares of Class A common stock at $3.9999 per warrant.

Chione Ltd.
Principal stockholder
Amount not stated

Chione Ltd. purchased 625,000 shares of Class A common stock in the public offering at $4.00 per share.

Real Endpoints LLC
Entity at which Jane F. Barlow, M.D., a member of our board of directors, is Executive Vice President and Chief Clinical Officer
$205,000

Consulting agreement (Statement of Work #1) for third-party payer engagement services; fees incurred under it.

Real Endpoints LLC
Entity at which Jane F. Barlow, M.D., a member of our board of directors, is Executive Vice President and Chief Clinical Officer
$30,000

Service agreement (Statement of Work #2) for pursuing third-party payer coverage for PreTRM; fees incurred before termination.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support